Linagliptin 5 mg tablet is an oral antidiabetic medication used to improve blood sugar control in adults with type 2 diabetes mellitus. It belongs to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in a glucose-dependent manner. Linagliptin is particularly beneficial for patients with renal impairment, as it is primarily excreted via the bile, requiring minimal dose adjustments. This once-daily tablet aids in maintaining glycemic control alongside diet and exercise.
